Savvy Updates, 11/11/24: Rotate Infusion Sites, Dawn Phenomenon, Hidden Disabilities Sunflower, Insulin Resistence, US Diabetes Rates Rise, Companion Cards/Diabetes By Design
The Savvy Diabetic Blog
by thesavvydiabetic
2d ago
Location, location, location. Does cannula site affect AID performance? by Tim Street for Diabettech.com, 7 November 2024. Rotate your injection or infusion sites. That’s a key message that anyone living with type 1 is delivered very early in their life with the condition. And for good reason. Nobody wants to have to live with scar tissue or lipohypertrophy affecting their insulin absorption. But within the advice about location lies another reality, before we get to any tissue damage ..read more
Visit website
Savvy Updates, 11/4/24: O5/iPhone, Abbott CGM & MRIs, FDA Rejects Sotagliflozin, Chinese Stem-Cell Therapies, Semaglutide & Arthritis, Beta Bionics & Libre 3 Plus, AI & Diabetic Cardiomyopathy, Insulcloud & Insulin Pens, Dexcom CCO Retires
The Savvy Diabetic Blog
by thesavvydiabetic
1w ago
In this week’s issue of The Savvy Diabetic:  Omnipod 5 & the iPhone App Abbott CGM Sensors OK in MRI FDA Rejects Sotagliflozin for T1D Chinese Stem Cell-Based Therapies Semaglutide for Knee Osteoarthritis Pain Beta Bionics Launches iLet with Abbott FreeStyle Libre 3 Plus AI For Diabetes with Cardiomyopathy Insulcloud Cleared by FDA for Insulin Pens Dexcom CCO to Retire Following Sales Restructuring Insulet rolls out iPhone app for Omnipod 5 insulin pump in US by GlobalData.com, 31 October 2024.  The app allows users to control the Omnipod 5 from the phone instead of carrying a ..read more
Visit website
Savvy Updates: 10/28/24: Insulin for BG Drops, Luna Diabetes Pivotal Trial, Levicure’s Triple-Combo Therapy, T1D GLP-1/SGLT2 Use, DTS Innovations, Semaglutide/T1D/Alzheimer’s, Hospitalizations by Age, Insurance Companies’ Woes
The Savvy Diabetic Blog
by thesavvydiabetic
2w ago
In this week’s issue of The Savvy Diabetic:  New Insulin to Prevent Sudden BG Drops Luna Diabetes Clinical Trial for AID Closed-Loop for MDI Levicure’s Triple-Combo Oral Therapy to Restore Insulin Production GLP-1, SGLT2 Drug Scripts on the Rise for T1Ds Diabetes Technology Society Showcased Innovations in Diabetes Management  Semaglutide Linked to Reduced Risk for Alzheimer’s in Diabetics Scientists Track Age You’re Most Likely to be Hospitalized Medicare Advantage Insurers Under Fire by US Senate MultiPlan Accused of Conspiring with Health Insurers to Underpay Doctors New t ..read more
Visit website
Savvy Updates, 10/21/24: Stem Cell Research News, GLP-1s with AIDs, FDA Removes GLP-1s from Shortage List, Tzield Delays T1D Onset in Teen
The Savvy Diabetic Blog
by thesavvydiabetic
3w ago
In this week’s issue of The Savvy Diabetic:  A Cure for T1D by Disguising Stem Cells? Stem Cell-Derived Islets Restore Insulin Production in T1D GLP1-RAs and T1D with Open Source AIDs FDA Removes Zepbound & Mounjaro from Shortage List Teen Receives Teplizumab (Tzield) to Delay Onset of T1D Scientist hopes to cure Type 1 diabetes by disguising stem cells by Brian Brennan for HealthSciences.arizona.edu, 9 October 2024 ..read more
Visit website
Savvy Updates 10/7/24: Somatostatin Protects Against Sudden BG Drops, Sernova’s Cell Pouch, A Spoonful of Laughter
The Savvy Diabetic Blog
by thesavvydiabetic
1M ago
It was a quiet week for diabetes news, in this issue of The Savvy Diabetic: Somatostatin May Protect Against Sudden BG Drops Sernova’s Cell Pouch Contains Vascularized, Functioning Islets > 5 years A Spoonful of Laughter for dStimatize.org (diaTribe) Potential strategy against blood glucose drops in type 1 diabetes by University of Gothenburg for ScienceDaily.com, 30 September 2024 ..read more
Visit website
Savvy Updates 9/30/24: Stem Cells, New CGM? Biomea Fusion, Wink Therapeutics, Sensulin, Heat/Dust Affects T1D, Gina Pillina T1D Artist
The Savvy Diabetic Blog
by thesavvydiabetic
1M ago
In this week’s issue of The Savvy Diabetic:  Stem cells Reverse T1D Microtech Linx CGM (a fail?) FDA Releases Clinical Hold on Biomea Fusion’s BMF-219  StartUp Health Podcast:  WiNK Therapeutics & Sensulin Heat/dust Increase Diabetes Hospitalizations Gina Pillina, T1D and Illustrator Extraordinaire! Stem cells reverse woman’s diabetes — a world first by Smriti Mallapaty for Nature.com, 26 September 2024.  A 25-year-old woman with type 1 diabetes started producing her own insulin less than three months after receiving a transplant of reprogrammed stem cells ..read more
Visit website
Savvy Updates, 9/23/24: G7 Geofencing Fix, Senseonics Eversense 365, Abbott Ramps Libre3 Production, AI Predicts Retinopathy, SuperCell Medicines, Stem Cell-Enabled Therapy, How to Appeal Insurance Denial, T1D & Brain Development, FTC & PMBs Sue Each Other, ChatGPT for Diagnosis
The Savvy Diabetic Blog
by thesavvydiabetic
1M ago
In this week’s issue of The Savvy Diabetic:  Geofencing/Dexcom G7 Update! with Jake Leach Senseonics Gets FDA Clearance for 1-year CGM Abbott Ramps Up Libre 3 Production AI Model to Predict Diabetic Retinopathy GC Therapeutics “Supercell” Medicines SymbioCellTech’s Stem Cell-Enabled Therapy How to Appeal Insurance Denials Type 1 Diabetes & Brain Development FTC & PMBs Sue Each Other Using ChatGPT to Diagnose  Geofencing/Dexcom G7 Update ..read more
Visit website
Savvy Updates, 9/16/24: Abbott Libre 3 Recall, FDA Clears Modular Medical PODD1 Pump, Air Flight Can Disrupt Pump Insulin Delivery, Roche to Launch Accu-Chek Smartguide CGM, Ozempic/Mounjaro & Metformin, Abvance Therapeutics Gets $3.9M for Novel Insulin & Glucagon Formulation, Dexcom CGM Worn in Space for 1st Time, Drug Interactions with GLP-1 Agonists & SGLT-2 Inhibitors, Semaglutide Impact on Body Composition, 4 largest PBMs Control 70% of Prescription Drug Market, Banana..
The Savvy Diabetic Blog
by thesavvydiabetic
2M ago
Continuous Glucose Monitoring (CGM) Sensor Recall: Abbott Diabetes Care Inc Issues Recall for Certain FreeStyle Libre 3 Sensors due to Risk for Inaccurate High Glucose Readings posted by FDA.gov/medical-devices, 5 September 2024. This recall involves removing certain devices from where they are used or sold, and does not apply to the FreeStyle Libre 3 reader or app. The FDA has identified this recall as the most serious type. This device may cause serious injury or death if you continue to use it.  This recall involves removing certain devices from where they are used ..read more
Visit website
Savvy Updates 9/9/24: Abbott Lingo 14-day OTC Sensor, Embecta Patch Pump FDA Clearance, Beta Bionics Partners with Abbott Libre3, Mental Resilience, TCOYD on Kidney Disease
The Savvy Diabetic Blog
by thesavvydiabetic
2M ago
Abbott debuts Lingo over-the-counter CGM in the US by Elise Reuter for MedTechDive.com, 6 September 2024.  Priced at $49 for one 14-day sensor, or $89 per month, Abbott’s offering is competitive with Dexcom’s Stelo sensor. Abbott’s Lingo is intended to show people how diet and exercise affect blood glucose levels. The sensor hardware is similar to Abbott’s prescription CGMs, but the app presents different information. The app includes a graph of glucose readings, a count of glucose spikes, and food and activity logging ..read more
Visit website
Savvy Updates 9/3/24: Dexcom/Stelo OTC CGM, Lilly Slashes Zepbound Prices, Personal CGMs Preferred by Patients/Staff, GluFormer AI Models Predict BG Levels, Smart Insulins & Type 1 Diabetes Grand Challenge, Best Exercise for Male/Female T1Ds, PBM Execs Facing Fines/Jail, Beta Bionics Reaches 10,000 iLet Users, Choose Cheese Wisely
The Savvy Diabetic Blog
by thesavvydiabetic
2M ago
Dexcom prices first over-the-counter glucose monitor by Elise Reuter for MedTechDive.com, 26 August 2024. Diabetes technology company Dexcom began selling its first over-the-counter continuous glucose monitor (CGM) on Monday. The device, called Stelo, will cost $89 for a monthly subscription or $99 for a one-time order of two sensors. BTIG analyst Marie Thibault said the price was “in line with our prior $100 per month assumption.”  Dexcom’s device is intended for people with Type 2 diabetes who don’t take insulin, although it can be used by people without diabetes ..read more
Visit website

Follow The Savvy Diabetic Blog on FeedSpot

Continue with Google
Continue with Apple
OR